Dynamic Effects of Lacunes of Presumed Vascular Origin on Health Status in Patients with Acute Ischemic Stroke
OU Ru1, LIU Yimin1, XU Zhijian1, HUANG Wenchun2
1Department of Neurology, Sixth People’s Hospital of Nanhai District, Foshan, Foshan 528000, China
2Department of Radiology, Sixth People’s Hospital of Nanhai District, Foshan, Foshan 528000, China
OU Ru, LIU Yimin, XU Zhijian, HUANG Wenchun. Dynamic Effects of Lacunes of Presumed Vascular Origin on Health Status in Patients with Acute Ischemic Stroke[J]. Chinese Journal of Stroke, 2026, 21(3): 312-319.
[1]MAHAMMEDI A,WANG L L,WILLIAMSON B J,et al. Small vessel disease,a marker of brain health:what the radiologist needs to know[J]. AJNR Am J Neuroradiol,2022,43(5):650-660.
[2] DE GRAAF J A,VISSER-MEILY J M,SCHEPERS V P,et al. Comparison between EQ-5D-5L and PROMIS-10 to evaluate health-related quality of life 3 months after stroke:a cross-sectional multicenter study[J]. Eur J Phys Rehabil Med,2021,57(3):337-346.
[3] SCHMIDT J,DÜVEL J A,ELKENKAMP S,et al. Comparing the EQ-5D-5L and stroke impact scale 2.0 in stroke patients:an analysis of measurement properties[J/OL]. Health Qual Life Outcomes,2024,22:45[2025-11-25]. https://doi.org/10.1186/s12955-024-02252-z.
[4] TAROZA S,BURKAUSKAS J,MICKUVIENE N,et al. Psychometrics and validation of the EQ-5D-5L instrument in individuals with ischemic stroke in Lithuania[J/OL]. Front Psychol,2023,14:1284859[2025-11-25]. https://doi.org/10.3389/fpsyg.2023.1284859.
[5] SCHÄBITZ M,MÖLLER L,FRIEDRICH A,et al. Long-term functional outcome and quality of life 2.5 years after thrombolysis in acute ischemic stroke[J/OL]. Neurol Res Pract,2023,5(1):62[2025-11-25]. https://doi.org/10.1186/s42466-023-00291-3.
[6] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志,2018,51(9):666-682.
Chinese Society of Neurology,Chinese Stroke Society. Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018[J]. Chin J Neurol,2018,51(9):666-682.
[7] SAVER J L,CHAISINANUNKUL N,CAMPBELL B C V,et al. Standardized nomenclature for modified Rankin scale global disability outcomes:consensus recommendations from Stroke Therapy Academic Industry Roundtable ⅩⅠ[J]. Stroke,2021,52(9):3054-3062.
[8] JIANG J Y,WANG D D,SONG Y,et al. Computer-aided extraction of select MRI markers of cerebral small vessel disease:a systematic review[J/OL]. Neuroimage,2022,261:119528[2025-11-25]. https://doi.org/10.1016/j.neuroimage.2022.119528.
[9] 欧茹,刘建平,刘益民,等. 血管源性腔隙灶与老年患者急性缺血性脑卒中后自发性出血性转化的相关性[J]. 中华老年心脑血管病杂志,2025,27(6):788-792.
OU R,LIU J P,LIU Y M,et al. Correlation between lacune of presumed vascular origin and spontaneous hemorrhagic transformation in elderly patients with AIS[J]. Chin J Geriatr Heart Brain Vessel Dis,2025,27(6):788-792.
[10] LUO N,LIU G,LI M H,et al. Estimating an EQ-5D-5L value set for China[J]. Value Health,2017,20(4):662-669.
[11] 欧茹,唐亚梅. 扩大的血管周围间隙与脑出血患者神经功能恢复及生活质量的关系[J]. 中国卒中杂志,2020,15(9):955-959.
OU R,TANG Y M. Correlation between enlarged perivascular space and the prognosis of patients with cerebral hemorrhage[J]. Chin J Stroke,2020,15(9):955-959.
[12] FAN R M,GAN J H,CHEN F,et al. Overall cerebral small vessel disease burden is associated with outcome of acute ischemic stroke after mechanical thrombectomy[J]. Interv Neuroradiol,2024,30(2):264-270.
[13] SPERBER C,HAKIM A,GALLUCCI L,et al. A typology of cerebral small vessel disease based on imaging markers[J]. J Neurol,2023,270(10):4985-4994.
[14] DIMARAS T,MERKOURIS E,TSIPTSIOS D,et al. Leukoaraiosis as a promising biomarker of stroke recurrence among stroke survivors:a systematic review[J]. Neurol Int,2023,15(3):994-1013.
[15] WARDLAW J M,SMITH C,DICHGANS M. Small vessel disease:mechanisms and clinical implications[J]. Lancet Neurol,2019,18(7):684-696.
[16] WANG J L,WANG B,WANG K X,et al. Review of neuroimaging research progress of cerebral small vessel disease[J]. Folia Neuropathol,2023,61(1):1-7.
[17] GAO Y,LI D,LIN J W,et al. Cerebral small vessel disease:pathological mechanisms and potential therapeutic targets[J/OL]. Front Aging Neurosci,2022,14:961661[2025-11-25]. https://doi.org/10.3389/fnagi.2022.961661. .
[18] ALSBROOK D L,DI NAPOLI M,BHATIA K,et al. Neuroinflammation in acute ischemic and hemorrhagic stroke[J]. Curr Neurol Neurosci Rep,2023,23(8):407-431.
[19] ENDRES M,MORO M A,NOLTE C H,et al. Immune pathways in etiology,acute phase,and chronic sequelae of ischemic stroke[J]. Circ Res,2022,130(8):1167-1186.
[20] XU X M,HUANG S,ZENG Y E,et al. Higher burden of cerebral small vascular disease predicts major adverse cardiac and cerebrovascular events and is related to abnormal blood pressure variability pattern in hypertension patients[J/OL]. Front Aging Neurosci,2022,14:824705[2025-11-25]. https://doi.org/10.3389/fnagi.2022.824705.
[21] YAN K Q,WU Q S,YANG J. Blood pressure variability may be a new predictor for the occurrence and prognosis of ischemic stroke[J]. Chin Med Sci J,2023,38(3):242-249.
[22] 皮成慧,王君,张荣举,等. 颅内侧支循环对急性脑梗死患者预后影响的研究进展[J]. 中国脑血管病杂志,2018,15(4):212-215.
PI C H,WANG J,ZHANG R J,et al. Research progress on the impact of intracranial collateral circulation on the prognosis of patients with acute cerebral infarction[J]. Chin J Cerebrovasc Dis,2018,15(4):212-215.
[23] LIANG Y,CHEN Y K,MOK V C,et al. Cerebral small vessel disease burden is associated with poststroke depressive symptoms:a 15-month prospective study[J/OL]. Front Aging Neurosci,2018,10:46[2025-11-25]. https://doi.org/10.3389/fnagi.2018.00046.
[24] FANG Y Y,QIN T T,LIU W H,et al. Cerebral small-vessel disease and risk of incidence of depression:a meta-analysis of longitudinal cohort studies[J/OL]. J Am Heart Assoc,2020,9(15):e016512[2025-11-25]. https://doi.org/10.1161/JAHA.120.016512.
[25]ZHOU L H,CHEN L C,MA L Q,et al. A new nomogram including total cerebral small vessel disease burden for individualized prediction of early-onset depression in patients with acute ischemic stroke[J/OL]. Front Aging Neurosci,2022,14:922530[2025-11-25]. https://doi.org/10.3389/fnagi.2022.922530.